Answers are grounded in this paper and cite their sources.
The authors describe the use of gabapentin in the treatment of 4 outpatients with dementia-associated agitation. On the basis of clinical case reports and the Overt Agitation Severity Scale, all 4 patients had reduced agitation with gabapentin. Three of 4 patients were successfully titrated to a full dose of 2,400mg/day. These findings suggest a possible role for gabapentin in the behavioral management of patients with dementia.
No takes yet. Share an insight, caveat, or question.
Roane et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: